Genpharm International, Inc.
Records under this name other than patents Genpharm International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Genpharm International, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,189,515 | Human Antibodies as Detection Reagents Formerly held Term ended Ended no later than Oct 13, 2021 · Medium confidence | Term ended | Ended no later than Oct 13, 2021 | Medium confidence |
| US 6,385,084 | Semiconductor memory Formerly held Term ended Term ended Nov 20, 2020 · USPTO record | Term ended | Term ended Nov 20, 2020 | USPTO record |
| US 6,680,209 | Human antibodies as diagnostic reagents Formerly held Term ended Term ended Dec 6, 2019 · USPTO record | Term ended | Term ended Dec 6, 2019 | USPTO record |
| US 7,084,260 | High affinity human antibodies and human antibodies against human antigens Term ended Term ended Jun 5, 2018 · USPTO record | Term ended | Term ended Jun 5, 2018 | USPTO record |
| US 6,255,458 | High affinity human antibodies and human antibodies against digoxin Term ended Term ended Mar 13, 2018 · USPTO record | Term ended | Term ended Mar 13, 2018 | USPTO record |
| US 6,140,552 | Production of recombinant polypeptides by bovine species and transgenic methods Term ended Term ended Oct 31, 2017 · USPTO record | Term ended | Term ended Oct 31, 2017 | USPTO record |
| US 7,722,873 | Heterologous antibodies which bind human CD4 Term ended Term ended May 24, 2017 · USPTO record | Term ended | Term ended May 24, 2017 | USPTO record |
| US 7,041,871 | Transgenic non-human animals capable of producing heterologous antibodies Term ended Term ended Feb 13, 2017 · USPTO record | Term ended | Term ended Feb 13, 2017 | USPTO record |
| US 6,013,857 | Transgenic bovines and milk from transgenic bovines Term ended Term ended Jan 11, 2017 · USPTO record | Term ended | Term ended Jan 11, 2017 | USPTO record |
| US 6,300,129 | Transgenic non-human animals for producing heterologous antibodies Term ended Term ended Dec 2, 2016 · USPTO record | Term ended | Term ended Dec 2, 2016 | USPTO record |